Peddock Capital Advisors, LLC Bristol Myers Squibb CO Transaction History

Peddock Capital Advisors, LLC

$387 Million
Q2 2024

A detailed history of Peddock Capital Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Peddock Capital Advisors, LLC holds 5,146 shares of BMY stock, worth $277,678. This represents 0.05% of its overall portfolio holdings.

Number of Shares

5,146

Previous 5,707 9.83%

Holding current value

$277,678

Previous $309,000 31.07%

% of portfolio

0.05%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	SELL	$40.25 - $52.99 $22,580 - $29,727	-561 Reduced 9.83%	5,146 $213,000
Q1 2024 May 03, 2024	BUY	$47.98 - $54.4 $47 - $54	1 Added 0.02%	5,707 $309,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $100,353 - $119,749	-2,070 Reduced 26.62%	5,706 $292,000
Q3 2023 Oct 10, 2023	BUY	$57.89 - $64.73 $173 - $194	3 Added 0.04%	7,776 $451,000
Q2 2023 Aug 07, 2023	SELL	$63.71 - $70.74 $61,034 - $67,768	-958 Reduced 10.97%	7,773 $497,000
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $919 - $1,043	-14 Reduced 0.16%	8,731 $605,000
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $205 - $243	3 Added 0.03%	8,745 $629,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $0 - $153	2 Added 0.02%	8,742 $621,000
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $4,575 - $5,038	-63 Reduced 0.72%	8,740 $673,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $23,423 - $28,087	-381 Reduced 4.15%	8,803 $643,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $27,458 - $32,010	-512 Reduced 5.28%	9,184 $573,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $138,871 - $162,670	-2,347 Reduced 19.49%	9,696 $574,000
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $52,623 - $57,307	-850 Reduced 6.59%	12,043 $817,000
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $59 - $66	1 Added 0.01%	12,893 $814,000
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $5,427 - $6,150	-94 Reduced 0.72%	12,892 $800,000
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $5,743 - $6,364	-100 Reduced 0.76%	12,986 $783,000
Q2 2020 Aug 11, 2020	SELL	$54.82 - $64.09 $48,186 - $56,335	-879 Reduced 6.29%	13,086 $769,000
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $26,169 - $38,030	-564 Reduced 3.88%	13,965 $778,000
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $428,766 - $559,287	8,713 Added 149.81%	14,529 $933,000
Q3 2019 Oct 16, 2019	BUY	$42.77 - $50.71 $42 - $50	1 Added 0.02%	5,816 $295,000
Q2 2019 Aug 06, 2019	BUY	$44.62 - $49.34 $44 - $49	1 Added 0.02%	5,815 $264,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $43,835 - $56,843	-899 Reduced 13.39%	5,814 $302,000
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $13,742 - $15,500	-249 Reduced 3.58%	6,713 $417,000
Q2 2018 Aug 03, 2018	SELL	$50.53 - $62.98 $27,488 - $34,261	-544 Reduced 7.25%	6,962 $385,000
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $35,292 - $40,629	-589 Reduced 7.28%	7,506 $475,000
Q4 2017 Feb 02, 2018	BUY	$59.94 - $65.35 $59 - $65	1 Added 0.01%	8,095 $496,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $447,031 - $515,911	8,094	8,094 $516,000

Others Institutions Holding BMY

# of Institutions

2,407

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peddock Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peddock Capital Advisors, LLC with notifications on news.

Account

Peddock Capital Advisors, LLC Bristol Myers Squibb CO Transaction History